Sign In
Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 09:20 AM IST

Anti-COVID drug developed by DRDO

In news

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO)

About the drug
  • The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
  • It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.
  • Its selective accumulation in virally infected cells makes this drug unique.
  • Clinical trial results of the drug have shown that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
Source: PIB, The Hindu

More Related Current Affairs View All

17 Jan

Groundwater contamination in India

'Of the 15,239 groundwater samples collected from across the country for testing, 19.8% samples had nitrates — nitrogenous compounds — above safe limits though it must

Read More

17 Jan

Draft data protection rules

'The Ministry of Electronics and Information Technology on January 3, 2025, released the the draft rules for implementing the Digital Personal Data Protection (DPDP) Act, 2023 &mda

Read More

16 Jan

INS Surat, INS Nilgiri and INS Vaghsheer commissioned

'PM Modi dedicated three frontline naval combatants to the nation on their commissioning.' The naval combatants – INS Surat, INS Nilgiri and INS Vaghsheer --were commissio

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps